Evidence map›Paper›PMID 35422544›Full record

ArticleAnesthesia, essays and researches

Myasthenia Gravis and COVID-19 - A Clinical Checkmate.

Vijayalakshmi Sivapurapu, Pratheeba Natarajan, Ravindra Raghuveera Bhat, R Remadevi

Open access · greenAbstract readCase Reports
In one paragraph

Article in Anesthesia, essays and researches. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vijayalakshmi SivapurapuDepartment of Anaesthesiology and Critical Care, Indira Gandhi Medical College and Research Institute, Puducherry, India.
Pratheeba NatarajanDepartment of Anaesthesiology and Critical Care, Indira Gandhi Medical College and Research Institute, Puducherry, India.
Ravindra Raghuveera BhatDepartment of Anaesthesiology and Critical Care, Indira Gandhi Medical College and Research Institute, Puducherry, India.
R RemadeviDepartment of Anaesthesiology and Critical Care, Indira Gandhi Medical College and Research Institute, Puducherry, India.
Indira Gandhi Medical College and Research Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myasthenia gravis (MG) patients with coronavirus disease (COVID-19) pose a unique challenge for intensive care management. Higher risk of infection is observed in patients with MG due to the immunosuppressant medications they are prescribed. The underlying component of respiratory muscle weakness predisposes these patients to experience a more severe form of illness. In the case of diagnosis of COVID-19 in MG patients, judicious continuation of immunosuppressants, avoiding drugs that worsen MG along with the continuation of cholinesterase inhibitors is prudent. Early diagnosis in cases with high-index of suspicion, extra precautions, COVID-appropriate behavior, and early immunization is paramount for the health of MG patients during this pandemic.

Indexed as

COVID-19immunosuppressive agentsmyasthenia gravis

Identifiers

PMID35422544
PMCPMC9004271
OpenAlexW4223921026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.